VeriSIM NIH Human-Based Research Toolkit: Unlocking Predictive Power, Reducing Costs, and Accelerating Translation │ Drug Discovery & Development Technology
NIH Human-Based Research Toolkit: Unlocking Predictive Power, Reducing Costs, and Accelerating Translation
Overview
The NIH’s groundbreaking shift to prioritize human-relevant science marks a paradigm change for biomedical research institutions. This toolkit outlines how VeriSIM Life’s BIOiSIM® platform enables researchers to align with NIH’s new direction, replacing traditional animal testing with predictive, clinically relevant AI-driven tools. For institutions, this shift doesn’t just improve science—it enhances funding competitiveness, reduces R&D costs, and accelerates translational impact.
Why It Matters for Institutions:
Increased NIH Funding Eligibility: Align with priority areas for new NIH grant opportunities focused on human-based research.
Lower Preclinical Costs: Reduce or eliminate animal studies, which often represent 30–50% of early-stage R&D budgets.
Faster Time to IND: BIOiSIM® de-risks candidates earlier, cutting 6–12 months from development timelines.
Higher Translational Success Rates: Replace low-predictive animal models with human-relevant simulations, increasing clinical success probability.
Reputation & Partnership Readiness:
Join a forward-looking ecosystem of AI-powered translational research and attract academic-industry collaborations.
